AMERICAN CENTURY COMPANIES INC - SANGAMO THERAPEUTICS INC ownership

SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 134 filers reported holding SANGAMO THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.23 and the average weighting 0.0%.

Quarter-by-quarter ownership
AMERICAN CENTURY COMPANIES INC ownership history of SANGAMO THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$75,728
-40.1%
44,546
+10.7%
0.00%
Q4 2022$126,350
-28.2%
40,239
+12.1%
0.00%
Q3 2022$176,000
+18.1%
35,906
-0.2%
0.00%
Q2 2022$149,000
-27.0%
35,995
+2.5%
0.00%
Q1 2022$204,000
-21.8%
35,125
+0.8%
0.00%
Q4 2021$261,000
-69.0%
34,843
-62.7%
0.00%
-100.0%
Q3 2021$841,000
-46.3%
93,345
-28.6%
0.00%0.0%
Q2 2021$1,565,000
-23.4%
130,703
-19.8%
0.00%
-50.0%
Q1 2021$2,042,000
+246.7%
162,965
+332.0%
0.00%
Q4 2020$589,000
+199.0%
37,725
+80.9%
0.00%
Q3 2020$197,000
-93.6%
20,857
-88.5%
0.00%
-100.0%
Q3 2018$3,068,000
-19.4%
181,009
-32.5%
0.00%
-25.0%
Q2 2018$3,808,000
-38.6%
268,198
-17.8%
0.00%
-33.3%
Q1 2018$6,199,000
-19.4%
326,275
-30.4%
0.01%
-25.0%
Q4 2017$7,693,000
+49.5%
469,099
+36.8%
0.01%
+60.0%
Q3 2017$5,145,000
+474.2%
342,978
+324.7%
0.01%
+400.0%
Q2 2015$896,000
-75.7%
80,756
-65.6%
0.00%
-75.0%
Q1 2015$3,682,000
+56.0%
234,811
+51.3%
0.00%
+33.3%
Q4 2014$2,360,000
+22.5%
155,172
-13.1%
0.00%
+50.0%
Q3 2014$1,927,000
+7.9%
178,645
+52.7%
0.00%0.0%
Q2 2014$1,786,000116,9650.00%
Other shareholders
SANGAMO THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Alexandria Capital, LLC 1,003,725$15,663,0001.66%
Golden State Equity Partners 123,817$1,932,0001.33%
Rhenman & Partners Asset Management AB 821,888$12,826,0001.05%
WASATCH ADVISORS LP 10,072,381$157,180,0000.77%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 29,636$462,0000.73%
Ceeto Capital Group, LLC 80,000$1,248,0000.63%
EMC Capital Management 48,992$765,0000.58%
Fort Sheridan Advisors LLC 71,173$1,111,0000.54%
Vanguard Capital Wealth Advisors 34,680$584,0000.54%
Casdin Capital, LLC 1,080,000$16,853,0000.50%
View complete list of SANGAMO THERAPEUTICS INC shareholders